I believe there is a greater need for Snorenz (or however you spell it) than the Rejuv and I would expect a big jump in revenue end of 1st qtr. My decision to hold will come from these results. On the other hand what irritates me most is the element of trust was somewhat diminished for me because the company was never up front about problems we ran into 1)paper certificates; 2) enormous revenue sales which didn't exactly happen as they implied; 3) legal issues pending. There is no need to be so evasive especially when you have a decent product. True transparency is great, but if you only tell us what you want and hold back on the negative is that really transparency. In other words IMO we would have been far better off if they were up front on these issues. Hopefully we don't see it again on the next PR/Shareholder notes.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.